GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Uniphar PLC (DUB:UPR) » Definitions » YoY EBITDA Growth

Uniphar (DUB:UPR) YoY EBITDA Growth : 28.34% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Uniphar YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Uniphar's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 28.34%.

Uniphar's EBITDA per Share for the six months ended in Dec. 2024 was €0.32.

Uniphar YoY EBITDA Growth Historical Data

The historical data trend for Uniphar's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uniphar YoY EBITDA Growth Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only -19.00 46.90 2.11 22.12 20.77

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.58 18.57 24.12 10.24 28.34

Uniphar YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Uniphar's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.5-0.414)/ | 0.414 |
=20.77 %

Uniphar's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.317-0.247)/ | 0.247 |
=28.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Uniphar's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Uniphar Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Uniphar PLC (DUB:UPR) » Definitions » YoY EBITDA Growth
Comparable Companies
MCK COR CAH ASX:SIG SHSE:601607 HSIC HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459 SHSE:600998 SHSE:600511 PDCO TSE:2784 TSE:9987 SHSE:600739 SHSE:600056 TSE:8129
Traded in Other Exchanges
UPR:UK 0NR:Germany
Address
4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Website
https://www.uniphar.ie
Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain and Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland.

Uniphar Headlines

No Headlines